Louise Charbonneau

No ORCID on file · 1 paper in corpus
review 2009
·doi:10.1016/j.contraception.2008.10.016

BackgroundIn the fall of 2007, the controversy about the contraceptive use of depot-medroxyprogesterone acetate (DMPA) and its potential impact on skeletal health reached the media in the province of Quebec, Canada, thereby becoming a matte…